This message contains search results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.

Sender's message:

Sent on Wednesday, 2006 May 17 GMT
Search "American journal of clinical pathology"[Jour] AND 116[volume] AND 4[issue] AND 473[page]

Entrez PubMed Results
Item 1 of 1
1: Am J Clin Pathol. 2001 Oct;116(4):473-6. Related Articles, Books, LinkOut
Click here to read 
Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations.

Arbiser ZK, Folpe AL, Weiss SW.

Department of Pathology and Laboratory Medicine, Emory University Hospital, 1364 Clifton Rd, Atlanta, GA 30322, USA.

We reviewed 500 consecutive soft tissue lesions referred for expert consultation to determine types of lesions and/or situations in which major discrepancies occur. Of 266 cases (53.2%) accompanied by a diagnosis, essential agreement with the second opinion was noted in 68%, minor discrepancy in 7%, and major discrepancy in 25%. The 65 major discrepancies were distributed proportionally to the referring sources and could be divided into 4 groups: benign mesenchymal lesions diagnosed as sarcomas (45%), sarcomas diagnosed as benign tumors (23%), nonmesenchymal lesions diagnosed as sarcoma (20%), and major grading discrepancies (12%). Relatively few lesions accounted for a major proportion of major discrepancies. Problematic lesions were lipoma and fasciitis and their variants and desmoplastic-neurotropic melanoma. Needle biopsy specimens were somewhat more likely to be associated with a discrepant opinion. With the exception of nonmesenchymal lesions, the diagnosis for all major discrepant cases could be made on the basis of the H&E-stained slides, suggesting that failure to perform immunostains did not account for discrepancies. Lack of familiarity with rare or unusual lesions is probably more significant in explaining diagnostic discrepancies than is the increasing use of needle biopsy or the failure to perform immunohistochemical analysis.

PMID: 11601130 [PubMed - indexed for MEDLINE]